title: Haemolytic anaemia after nucleotide antiretroviral treatment discontinuation in a chronic hepatitis B-virus co-infected AIDS patient.
authors.forename: Christoph
authors.initials: C
authors.lastname: Stephan
authors.forename: Hans-Reinhard
authors.initials: HR
authors.lastname: Brodt
authors.forename: Annemarie
authors.initials: A
authors.lastname: Berger
authors.forename: Thomas
authors.initials: T
authors.lastname: Lutz
authors.forename: Manfred
authors.initials: M
authors.lastname: Mösch
authors.forename: Tessa-Suntje
authors.initials: TS
authors.lastname: Lennemann
authors.forename: Martin
authors.initials: M
authors.lastname: Stürmer
authors.forename: Schlomo
authors.initials: S
authors.lastname: Staszewski
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D000328:Adult; D000743:Anemia, Hemolytic / Q000188:drug therapy*; D023241:Antiretroviral Therapy, Highly Active; D015658:HIV Infections / Q000150:complications*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D063065:Organophosphonates / Q000627:therapeutic use*; D000068698:Tenofovir
chemical_list: D063065:Organophosphonates; D019259:Lamivudine; D000068698:Tenofovir; D000225:Adenine